Metropolis Healthcare achieves revenue growth of 40% in Q4FY21

08 Apr 2021 Evaluate

Metropolis Healthcare has achieved a revenue growth of 40% Year on Year (YoY) in Q4FY21 as compared to Q4FY20. Non-Covid Business revenue increased by 21% YoY in Q4FY21 as compared to Q4FY20. Inspite of conducting higher Covid Tests on QoQ basis, Covid Business revenue (RT-PCR Tests) stood at 14% of total revenue in Q4FY21 as compared to 19% in Q3FY21 due to reduction in Test prices by Government agencies.

The Company recorded highest ever monthly revenue in March 2021 on the back of strong growth in Non-covid business coupled with an uptick in covid business.

Metropolis Healthcare offers a comprehensive range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.

Metropolis Health. Share Price

1923.30 -6.10 (-0.32%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7189.25
Max Healthcare Inst 1097.95
Narayana Hrudayalay 1916.45
Aster DM Healthcare 635.10
Global Health 1163.75
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×